ArkGen
ArkGen Pharma Private Limited is a Bangalore-based pharmaceutical company that develops and supplies Active Pharmaceutical Ingredients, Key Starting Materials, and regulatory support services to global pharmaceutical and generic-drug manufacturers.
- Company typePrivate
- Founded-
- HeadquartersBangalore, India
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What ArkGen does
ArkGen Pharma Private Limited is a Bangalore-based, privately-held pharmaceutical company that researches, develops, and produces Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), Regulatory Starting Materials, and Related Substances for the global pharmaceutical industry. The company's commercial offering spans a portfolio of approximately 10 APIs (including Cabergoline, Valganciclovir Hydrochloride, Misoprostol, Levothyroxine Sodium, Brimonidine Tartrate, Fingolimod Hydrochloride, Rasagiline Mesylate, Olopatadine Hydrochloride, and Ripasudil Hydrochloride) and 15 KSMs, alongside a related-substances line of certified reference standards, impurities, and metabolites.
The company operates an asset-light manufacturing model, outsourcing production to contract partner Mavion Pharmasciences Pvt Ltd at a facility in Attibele Industrial Area, Bangalore, while retaining its R&D and regulatory capabilities in-house. Core technical competencies center on route scouting, process optimization, impurity profiling, and analytical method development aligned with ICH and global pharmacopeial standards (USP, IP, Ph.Eur, IH). ArkGen pairs its ingredient supply business with a regulatory services practice covering DMF preparation, ANDA lifecycle support, regulatory deficiency response, process development and scale-up, and technology transfer — positioning the company as a one-stop development partner for generic pharmaceutical manufacturers.
ArkGen monetizes through direct B2B sales of APIs and KSMs to formulation manufacturers (priced per project/order) and through professional services engagements for regulatory documentation and lifecycle support. The company targets two primary customer segments: large global pharmaceutical companies requiring compliant API supply, and generic manufacturers filing ANDAs who need both ingredients and regulatory support. The company serves 21 clients with 170 cumulative projects delivered over approximately five years, is FORM 37 accredited, and is led by Dr. P. M. Akbarali (Chairman & Managing Director), a pharmaceutical veteran with 36+ years of experience, 12 patents, and 25 scientific publications.
ArkGen firmographics
Firmographics- Name
- ArkGen
- Legal name
- ArkGen Pharma Private Limited
- Website
- https://arkgenpharma.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ArkGen Pharma Private Limited is a Bangalore-based pharmaceutical company that develops and supplies Active Pharmaceutical Ingredients, Key Starting Materials, and regulatory support services to global pharmaceutical and generic-drug manufacturers.
- Ownership category
- akta.pro rank
ArkGen industry classification
Industry- Product category
- Pharmaceutical API Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Industrial Organic Chemicals (2860), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Small-Molecule API Commercial Manufacturing (HLAGAHAB)
- akta.pro secondary industries
- Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)
Keywords
Where ArkGen is headquartered
LocationHeadquarters
- HQ city
- Bangalore
- HQ country
- India
- HQ region
- Asia
Offices2 records
Markets served
ArkGen business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- API Sales: Sale of Active Pharmaceutical Ingredients to pharmaceutical manufacturers for formulation into finished dosage forms
- KSM Sales: Sale of Key Starting Materials and Regulatory Starting Materials for pharmaceutical manufacturing
- Regulatory Services: DMF preparation and support, ANDA lifecycle support, regulatory deficiency responses, and technology transfer services
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
ArkGen product offering
Product offeringCore offering
ArkGen Pharma researches, develops, and manufactures Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), Regulatory Starting Materials, and Related Substances for global pharmaceutical formulation manufacturers. The company supplies a portfolio of 10+ named APIs and 15+ KSMs, complemented by end-to-end regulatory support services including DMF preparation, ANDA lifecycle support, regulatory deficiency responses, process development and scale-up, and technology transfer. Operations follow ICH guidelines and FORM 37 accreditation, with manufacturing conducted through partner facility Mavion Pharmasciences Pvt Ltd.
Product overview
ArkGen Pharma is a research-driven pharmaceutical company specializing in Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), Regulatory Starting Materials, and Related Substances. The company offers a portfolio of 10+ named APIs and 15+ KSMs, supported by comprehensive regulatory services including DMF preparation and support, ANDA lifecycle support, regulatory deficiency responses, process development and scale-up, and technology transfer. The product portfolio includes therapeutic APIs such as Cabergoline, Valganciclovir, Misoprostol, Levothyroxine Sodium, Brimonidine Tartrate, Fingolimod Hydrochloride, Rasagiline Mesylate, Olopatadine Hydrochloride, and Ripasudil Hydrochloride, alongside various API intermediates and pharmaceutical intermediates.
Differentiator
Problem solved
Functional benefit
Products and services
- CABERGOLINE USP / IP / Ph.Eur API product compliant with USP, IP, and Ph.Eur pharmacopeial standards for use in pharmaceutical formulation manufacturing.
- VALGANCICLOVIR HYDROCHLORIDE USP Antiviral API product compliant with USP standards for use in pharmaceutical formulation manufacturing.
- MISOPROSTOL USP 1% HPMC API product in 1% HPMC formulation, compliant with USP standards for pharmaceutical formulation manufacturing.
- LEVOTHYROXINE SODIUM USP / IP Thyroid hormone API compliant with USP and IP pharmacopeial standards for pharmaceutical formulation manufacturing.
- PYRIDOXAMINE DIHYDROCHLORIDE IH Vitamin B6 derivative API for pharmaceutical applications and formulation manufacturing.
- NEPAFENAC IH / USP NSAID API compliant with IH and USP standards for ophthalmic pharmaceutical formulation manufacturing.
- BRIMONIDINE TARTRATE Ph.Eur Alpha-2 adrenergic agonist API compliant with European Pharmacopoeia for pharmaceutical formulation manufacturing.
- FINGOLIMOD HYDROCHLORIDE Immunosuppressant API for multiple sclerosis treatment in pharmaceutical formulation manufacturing.
- RASAGILINE MESYLATE MAO-B inhibitor API for Parkinson's disease treatment in pharmaceutical formulation manufacturing.
- OLOPATADINE HYDROCHLORIDE USP Antihistamine API for allergic rhinitis and conjunctivitis treatment in pharmaceutical formulation manufacturing.
- RIPASUDIL HYDROCHLORIDE HYDRATE IH Rho-associated protein kinase inhibitor API for glaucoma treatment in pharmaceutical formulation manufacturing.
- DMF preparation and support End-to-end regulatory and process development support for Drug Master File preparation and submission, offered to pharmaceutical manufacturers.
- ANDA lifecycle support Comprehensive DMF, ANDA, and Technology Transfer assistance throughout the product lifecycle for pharmaceutical manufacturers.
- Regulatory deficiency responses Full lifecycle support for addressing regulatory deficiencies in pharmaceutical development processes for pharmaceutical manufacturers.
- Process development and scale-up Regulatory, development, and scale-up expertise for transitioning processes from R&D to commercial production, offered to pharmaceutical manufacturers.
- Technology transfer Complete support for pharmaceutical process and compliance during technology transfer operations for pharmaceutical manufacturers.
Quantifiable outcome
- 170 projects successfully delivered
- +1 more outcomes
Companies that use ArkGen
Customer profileSegments2 records
Ideal customer profiles2 records
ArkGen technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
ArkGen partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Mavion Pharmasciences Pvt LtdcoreMavion Pharmasciences Pvt Ltd serves as the manufacturing site for ArkGen Pharma. The facility is located at Plot No. 11/2, Attibele Industrial Area, Balagaranahalli, Anekal Taluk, Bangalore – 562 107, Karnataka, India.
Scale indicators7 records
Recent moves1 record
Expansion highlights4 records
ArkGen competitors and assessment
Company assessmentDirect peers
- Piramal Pharma Solutions: Large Indian CDMO offering API development and manufacturing, including DMF/CMC support, across multiple therapeutic areas. Operates in the same space as ArkGen but at greater scale, making it a scaled-up comparable.
- Sai Life Sciences: India-headquartered CDMO providing API process development, analytical services, and regulatory support to global pharma companies. Directly comparable service mix (development + regulatory + scale-up) and target customers overlap with ArkGen.
- Neuland Laboratories: Indian CDMO and small-molecule API manufacturer offering contract development, regulatory support (DMF/ANDA), and commercial API supply. Highly comparable business model to ArkGen with similar therapeutic breadth and customer base of generic pharma firms.
Broad incumbents
- Jubilant Ingrevia: Indian CDMO offering APIs, intermediates, and contract development services to global pharma. Overlaps with ArkGen on API development and regulatory support, but with significantly broader scale and an established CDMO platform.
- Granules India: Indian pharmaceutical company with active pharmaceutical ingredient manufacturing for global generics markets. Comparable in API focus and customer segment, though operates at much greater scale and with finished dosage capabilities.
- Divis Laboratories: Indian API manufacturer specializing in generics APIs and intermediates with strong global regulatory footprint. Comparable in API/intermediates work, though much larger and more focused on a narrower set of molecules.
- Aurobindo Pharma: Vertically integrated Indian pharmaceutical major with significant small-molecule API operations supplying global generics markets. Overlaps on APIs like Levothyroxine and Valganciclovir, but operates at vastly larger scale across finished dosage forms too.
- Laurus Labs: One of India's leading API manufacturers with a broad small-molecule API portfolio across antivirals, oncology, and ophthalmology — several of which overlap with ArkGen's product list. Larger scale and broader geographic reach make it an incumbent benchmark rather than a like-for-like competitor.
Emerging players
- Syngene International: Indian CRO/CDMO offering development and analytical services to global pharma. While more discovery-research oriented than ArkGen, it competes for the same 'India-based outsourced pharma services' wallet and demonstrates the broader India CDMO positioning ArkGen is targeting.
Regional players
- Apotex Pharmachem India: Indian subsidiary of Canada's Apotex (where CMD Dr. P.M. Akbarali previously served as Managing Director). Directly relevant given the leadership lineage and operates in the same small-molecule API + regulatory support segment with a global generics customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
ArkGen social profiles
Digital presenceArkGen compliance and trust
Trust signalCompliance2 records
ArkGen financial estimates
Financial estimateRevenue estimate
Valuation estimate
ArkGen leadership team
Management profileNumber of profiles
Profiles3 records
ArkGen funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ArkGen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ArkGen
What does ArkGen do?
ArkGen Pharma researches, develops, and manufactures Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), Regulatory Starting Materials, and Related Substances for global pharmaceutical formulation manufacturers. The company supplies a portfolio of 10+ named APIs and 15+ KSMs, complemented by end-to-end regulatory support services including DMF preparation, ANDA lifecycle support, regulatory deficiency responses, process development and scale-up, and technology transfer. Operations follow ICH guidelines and FORM 37 accreditation, with manufacturing conducted through partner facility Mavion Pharmasciences Pvt Ltd.
Is ArkGen a public or private company?
ArkGen is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ArkGen founded?
ArkGen was founded in -1. It employs 11 to 50 people.
Where is ArkGen based?
ArkGen is headquartered in Bangalore, India, in the Asia region.
How does ArkGen make money?
Three revenue lines are on record. API Sales are the primary driver. The others are KSM Sales and regulatory Services.
Who are ArkGen's main competitors?
Direct peers on record are Piramal Pharma Solutions, Sai Life Sciences and Neuland Laboratories. Broad incumbents are Jubilant Ingrevia, Granules India, Divis Laboratories, Aurobindo Pharma and Laurus Labs. Syngene International is listed as an emerging player. Apotex Pharmachem India is listed as a regional player.
Does ArkGen have an API?
No public API is recorded for ArkGen.
What industry is ArkGen in?
ArkGen's product category is Pharmaceutical API Manufacturing. Its primary akta.pro industry code is HLAGAHAB, Small-Molecule API Commercial Manufacturing, with a secondary code of HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 3254 and its SIC code is 2860.